Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV and T-cell dynamics after influenza vaccination in elderly adults
NL-OMON43423Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of ARCT-2138 and deuterated water in influenza, sponsored by National Institute for Public Health and the Environment. Started Jun 2016; status: active, not recruiting.
02
Drugs
ARCT-2138deuterated water
03
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON43423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43423.